Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.
Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S, Wagner H, Kirschning CJ.
Meng G, et al. Among authors: busch dh.
J Clin Invest. 2004 May;113(10):1473-81. doi: 10.1172/JCI20762.
J Clin Invest. 2004.
PMID: 15146245
Free PMC article.